Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Related Citations for PubMed (Select 20514017)

1.

Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Suraneni MV, Schneider-Broussard R, Moore JR, Davis TC, Maldonado CJ, Li H, Newman RA, Kusewitt D, Hu J, Yang P, Tang DG.

Oncogene. 2010 Jul 29;29(30):4261-75. doi: 10.1038/onc.2010.197. Epub 2010 May 31.

2.

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells.

Bhatia B, Tang S, Yang P, Doll A, Aumüeller G, Newman RA, Tang DG.

Oncogene. 2005 May 19;24(22):3583-95.

PMID:
15750631
3.

Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.

Suraneni MV, Moore JR, Zhang D, Badeaux M, Macaluso MD, DiGiovanni J, Kusewitt D, Tang DG.

Cell Cycle. 2014;13(11):1798-810. doi: 10.4161/cc.28757. Epub 2014 Apr 14.

4.

Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants.

Bhatia B, Maldonado CJ, Tang S, Chandra D, Klein RD, Chopra D, Shappell SB, Yang P, Newman RA, Tang DG.

J Biol Chem. 2003 Jul 4;278(27):25091-100. Epub 2003 Apr 18.

5.

Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.

Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG.

J Biol Chem. 2002 May 3;277(18):16189-201. Epub 2002 Feb 11.

6.

15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).

Tang DG, Bhatia B, Tang S, Schneider-Broussard R.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):135-46. Epub 2006 Jul 7. Review.

PMID:
17164141
7.

Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells.

Tang S, Bhatia B, Zhou J, Maldonado CJ, Chandra D, Kim E, Fischer SM, Butler AP, Friedman SL, Tang DG.

Oncogene. 2004 Sep 9;23(41):6942-53.

PMID:
15247906
8.

Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.

Guo Y, Sklar GN, Borkowski A, Kyprianou N.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2269-74.

9.

Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.

Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ.

Cancer Res. 2003 May 1;63(9):2256-67.

10.
11.

Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.

Shim EH, Johnson L, Noh HL, Kim YJ, Sun H, Zeiss C, Zhang H.

Cancer Res. 2003 Apr 1;63(7):1583-8.

12.

Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation.

Wang H, Xu Y, Fang Z, Chen S, Balk SP, Yuan X.

PLoS One. 2012;7(7):e41330. doi: 10.1371/journal.pone.0041330. Epub 2012 Jul 23.

13.
14.

Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model.

Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J.

PLoS One. 2009 May 22;4(5):e5662. doi: 10.1371/journal.pone.0005662.

15.

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR.

Cancer Cell. 2008 Aug 12;14(2):146-55. doi: 10.1016/j.ccr.2008.06.002.

16.

Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB.

Neoplasia. 2004 Nov-Dec;6(6):821-30.

17.

Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe.

Konno-Takahashi N, Takeuchi T, Nishimatsu H, Kamijo T, Tomita K, Schalken JA, Teshima S, Kitamura T.

Eur Urol. 2004 Jul;46(1):126-32.

PMID:
15183558
18.
19.

Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions.

Sen M, McHugh K, Hutzley J, Philips BJ, Dhir R, Parwani AV, Kelavkar UP.

Prostaglandins Other Lipid Mediat. 2006 Oct;81(1-2):1-13. Epub 2006 Jul 25.

PMID:
16997127
20.

Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.

Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi EF, Katz AE, Benson MC.

Urology. 2000 Jul;56(1):160-6.

PMID:
10869659
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk